Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06150560 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial
NCT06150560 · ClinicalTrials.gov record · last posted 2026-08-11

A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)

Study acronym: VALUE
StatusEnrolling by Invitation
PhasePhase 3
Started2024-04-01
View on ClinicalTrials.gov ↗
from the ClinicalTrials.gov record
The purpose of this study is to evaluate the effectiveness and mechanism of action of Losartan in the treatment of coarctation of aorta.

Protocol amendment history 3 changes detected by DataLookout

2026-08-12
Trial status changed: Recruiting → Enrolling by Invitation
2026-08-12
Primary completion pushed: 2028-06-01 → 2028-07-01
2026-08-12
Completion pushed: 2028-06-01 → 2028-07-01
Trial Details
NCT Number NCT06150560
Lead Sponsor Mayo Clinic
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Coarctation of Aorta, High Blood Pressure
Enrollment 120 participants
Start Date 2024-04-01
Primary Completion 2028-07-01 (estimated)
Study Completion 2028-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-11